Published in Biochem Pharmacol on October 01, 1977
A dominant trifluoperazine resistance gene from Saccharomyces cerevisiae has homology with F0F1 ATP synthase and confers calcium-sensitive growth. Mol Cell Biol (1988) 1.43
Multiple receptors for brain dopamine. Proc Natl Acad Sci U S A (1978) 1.11
Disturbed behavior induced by high-dose antipsychotic drugs. Br Med J (1980) 0.98
Some taste substances are direct activators of G-proteins. Biochem J (1994) 0.91
Extrapyramidal and depressive side reactions with flunarizine and cinarizine. J Neurol Neurosurg Psychiatry (1989) 0.77
Expression of a proteolipid gene from a high-copy-number plasmid confers trifluoperazine resistance to Saccharomyces cerevisiae. Mol Cell Biol (1990) 0.77
Quantitative determination of dopamine receptor subtypes not linked to activation of adenylate cyclase in rat striatum. Proc Natl Acad Sci U S A (1982) 0.76
Human platelet function as a model for investigating the clinical efficacy of chlorpromazine. Br J Clin Pharmacol (1981) 0.75
Binding of [3H]-neuroleptics to dopamine receptors on rat cerebral membranes [proceedings]. Br J Pharmacol (1978) 0.75
Fluoxetine reverses behavior changes in socially isolated rats: role of the hippocampal GSH-dependent defense system and proinflammatory cytokines. Eur Arch Psychiatry Clin Neurosci (2017) 0.75
The membrane actions of anesthetics and tranquilizers. Pharmacol Rev (1972) 11.00
Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature (1991) 4.36
Multiple dopamine D4 receptor variants in the human population. Nature (1992) 4.08
Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry (2001) 3.66
Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science (1975) 3.12
Brain dopamine receptors. Pharmacol Rev (1980) 2.88
Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature (1976) 2.85
The displacement of membrane calcium by a local anesthetic (chlorpromazine). Biochim Biophys Acta (1969) 2.83
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature (1991) 2.41
Transient holes in the erythrocyte membrane during hypotonic hemolysis and stable holes in the membrane after lysis by saponin and lysolecithin. J Cell Biol (1967) 2.40
Membrane formation by the adenosine triphosphatase of sarcoplasmic reticulum. J Biol Chem (1971) 2.34
Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology (1996) 2.18
The proton relaxation of benzyl alcohol in erythrocyte membranes. Mol Pharmacol (1968) 2.17
Brain receptors for antipsychotic drugs and dopamine: direct binding assays. Proc Natl Acad Sci U S A (1975) 2.16
The membrane concentrations of neutral and positive anesthetics (alcohols, chlorpromazine, morphine) fit the Meyer-Overton rule of anesthesia; negative narcotics do not. Biochim Biophys Acta (1972) 2.02
The membrane concentration of a local anesthetic (chlorpromazine). Biochim Biophys Acta (1969) 1.86
A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. Arch Gen Psychiatry (2000) 1.71
Ultrastructure of membrane lesions in immune lysis, osmotic lysis and drug-induced lysis. Fed Proc (1974) 1.64
The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia. Genes Brain Behav (2006) 1.63
D1 and D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci U S A (1991) 1.55
Receptor basis for dopaminergic supersensitivity in Parkinson's disease. Nature (1978) 1.52
Ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D2 receptor. Biol Psychiatry (2001) 1.42
Reversible drug-induced parkinsonism. Clinicopathologic study of two cases. Arch Neurol (1982) 1.36
Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action. J Psychiatry Neurosci (2000) 1.35
NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia. Mol Psychiatry (2002) 1.33
Calcium reversal of nerve blockade by alcohols, anesthetics, tranquilizers, and barbiturates. Can J Physiol Pharmacol (1974) 1.31
Membrane expansion of the erythrocyte by both the neutral and ionized forms of chlorpromazine. Biochim Biophys Acta (1969) 1.29
The site of action of caffeine and procaine in skeletal muscle. J Pharmacol Exp Ther (1971) 1.29
Bimodal distribution of dopamine receptor densities in brains of schizophrenics. Science (1984) 1.28
New detection of brain dopamine receptors with (3H)dihydroergocryptine. Proc Natl Acad Sci U S A (1977) 1.28
The membrane concentrations of alcohol anesthetics. Biochim Biophys Acta (1971) 1.27
Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharmacology (Berl) (2000) 1.25
Structure of membrane holes in osmotic and saponin hemolysis. J Cell Biol (1973) 1.21
Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug. Proc Natl Acad Sci U S A (1976) 1.20
Membrane expansion of intact erythrocytes by anesthetics. Biochim Biophys Acta (1969) 1.19
Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains. Nature (1978) 1.19
Dopamine D2 receptor dimers and receptor-blocking peptides. Biochem Biophys Res Commun (1996) 1.18
The effect of membrane-strain rate and of temperature on erythrocyte fragility and critical hemolytic volume. Biochim Biophys Acta (1969) 1.14
Direct evidence for presynaptic and postsynaptic dopamine receptors in brain. Nature (1978) 1.13
Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions. Proc Natl Acad Sci U S A (1981) 1.12
Multiple receptors for brain dopamine. Proc Natl Acad Sci U S A (1978) 1.11
The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form. Endocrinology (1985) 1.10
L-DOPA reversal of hyperdopaminergic behaviour. Life Sci (1978) 1.09
A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization. J Biol Chem (1998) 1.04
Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia. Genes Brain Behav (2010) 1.04
The nerve impulse-blocking actions of tranquilizers and the binding of neuroleptics to synaptosome membranes. J Pharmacol Exp Ther (1974) 1.03
Increased expression of calcium/calmodulin-dependent protein kinase IIbeta in frontal cortex in schizophrenia and depression. Synapse (2006) 1.02
The erythrocyte ghost is a perfect osmometer. J Gen Physiol (1970) 1.01
All lipid-soluble anaesthetics protect red cells. Nat New Biol (1971) 0.98
Elevation of brain neuroleptic/dopamine receptors in schizophrenia. Am J Psychiatry (1980) 0.97
The dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus. J Neurochem (1991) 0.97
Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert. Brain Res Mol Brain Res (2002) 0.97
Membrane lesions in immune lysis: surface rings, globule aggregates and transient openings. J Cell Biol (1973) 0.97
Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptor. J Biol Chem (1986) 0.97
Dopamine D2 receptor binding sites for agonists. A tetrahedral model. Mol Pharmacol (1985) 0.96
The impulse-blocking concentrations of anesthetics, alcohols, anticonvulsants, barbiturates, and narcotics on phrenic and sciatic nerves. Can J Physiol Pharmacol (1974) 0.96
General anesthetics expand cell membranes at surgical concentrations. Biochim Biophys Acta (1972) 0.96
The hydrophobic expansion of erythrocyte membranes by the phenol anesthetics. Biochim Biophys Acta (1972) 0.96
Erythrocyte membrane stabilization by steroids and alcohols; a possible model for anesthesia. Biochem Pharmacol (1966) 0.96
Anesthetics expand erythrocyte membranes without causing loss of K + . Biochim Biophys Acta (1972) 0.96
In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine: differential findings with [3H]raclopride versus [3H]spiperone. Mol Pharmacol (2003) 0.95
Dopamine D2 receptor dimers in human and rat brain. FEBS Lett (1998) 0.94
Dopaminergic supersensitivity after neuroleptics: time-course and specificity. Psychopharmacology (Berl) (1978) 0.94
Membrane expansion of erythrocyte ghosts by tranquilizers and anesthetics. Biochim Biophys Acta (1969) 0.94
Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors. Life Sci (1977) 0.94
Nijmegen breakage syndrome (NBS) with neurological abnormalities and without chromosomal instability. J Med Genet (2005) 0.93
Photoaffinity labeling of dopamine D1 receptors. Biochemistry (1988) 0.93
Suppression and enhancement of antibody formation by alteration of Ca2+ levels. Nature (1970) 0.93
Effect of antidepressant drugs on serotonergic and adrenergic receptors. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.93
High frequency of SH3TC2 mutations in Czech HMSN I patients. Clin Genet (2011) 0.93
Effect of denervating skeletal muscle on calcium binding by isolated sarcolemma. Exp Neurol (1971) 0.93
Dopamine receptor parameters detected by [3H]spiperone depend on tissue concentration: analysis and examples. J Neurochem (1984) 0.93
Cloning and characterization of additional members of the G protein-coupled receptor family. Biochim Biophys Acta (2000) 0.92
Membrane expansion by vinblastine and strychnine. Nat New Biol (1973) 0.91
Dopamine D2 receptor binding subunits of Mr congruent to 140,000 and 94,000 in brain: deglycosylation yields a common unit of Mr congruent to 44,000. Mol Pharmacol (1988) 0.91
Alcohol tolerance in a cholinergic nerve terminal: relation to the membrane expansion-fluidization theory of ethanol action. Science (1977) 0.91
The control of membrane-bound Ca 2+ by ATP. Biochim Biophys Acta (1971) 0.90
Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors. Eur J Pharmacol (1979) 0.90
Dopamine D2 receptor density remains constant in treated Parkinson's disease. Ann Neurol (1986) 0.90
Mutations in HINT1 are one of the most frequent causes of hereditary neuropathy among Czech patients and neuromyotonia is rather an underdiagnosed symptom. Neurogenetics (2014) 0.90
Elevation of dopamine D2 receptors in schizophrenia is underestimated by radioactive raclopride. Arch Gen Psychiatry (1990) 0.90
Conduction-blocking concentrations of anesthetics increase with nerve axon diameter: studies with alcohol, lidocaine and tetrodotoxin on single myelinated fibers. J Pharmacol Exp Ther (1977) 0.88
Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states. J Neurochem (1985) 0.88
Visualization of dopamine D1, D2 and D3 receptor mRNAs in human and rat brain. Neurochem Int (1992) 0.87
Dopamine D1 receptor mutagenesis: role of amino acids in agonist and antagonist binding. Biochem Biophys Res Commun (1993) 0.87
Visualization of a dopamine D1 receptor mRNA in human and rat brain. Brain Res Mol Brain Res (1991) 0.87
Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide. J Neurochem (1985) 0.87
Letter: cH OR PH. Can Med Assoc J (1975) 0.86
Resistance of the dopamine D2L receptor to desensitization accompanies the up-regulation of receptors on to the surface of Sf9 cells. Endocrinology (1997) 0.86
Transcription of a human dopamine D5 pseudogene. Biochem Biophys Res Commun (1991) 0.86
The human dopamine D5 receptor gene: cloning and characterization of the 5'-flanking and promoter region. Biochemistry (1995) 0.86
Simple PCR amplification of the entire glucocerebrosidase gene (GBA) coding region for diagnostic sequence analysis. DNA Seq (1998) 0.86
A human serotonin 1D receptor variant (5HT1D beta) encoded by an intronless gene on chromosome 6. Proc Natl Acad Sci U S A (1992) 0.86
DFNB49 is an important cause of non-syndromic deafness in Czech Roma patients but not in the general Czech population. Clin Genet (2011) 0.85
Cloning of two additional catecholamine receptors from rat brain. FEBS Lett (1990) 0.85
The dopamine-releasing actions of neuroleptics and ethanol. J Pharmacol Exp Ther (1974) 0.85
Serotonin receptor cDNA cloned from Lymnaea stagnalis. Proc Natl Acad Sci U S A (1993) 0.85
Autoradiographic localization of [3H]quinpirole binding to dopamine D2 and D3 receptors in rat brain. Eur J Pharmacol (1992) 0.85
Schizophrenia: elevated mRNA for dopamine D2(Longer) receptors in frontal cortex. Brain Res Mol Brain Res (2001) 0.84
Images in neuroscience. Brain development, X: pruning during development. Am J Psychiatry (1999) 0.84